Overall rank by patents
#43,806
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Ureka SARL
USPTO PatentsView assignee record - 6 granted patents across 9 technology areas, active 2019–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).
6
Total patents granted
9
CPC technology areas
17.5
Avg claims per patent
+0%
5-year filing velocity
The verdict
Ureka holds 6 US patents across 9 technology areas, rank #43,806 of 50,000 tracked assignees.
- #43,806
- of 50,000 US assignees by volume
- Top 63%
- by Innovation Score (31.2/100)
- 17.5
- avg claims per patent
- +0%
- filing velocity, last 5 yrs
Portfolio overview
Ureka SARL has been granted 6 US utility patents between 2019 and 2022, placing Ureka SARL at rank #43,806 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.5 claims per patent with primary concentration in C07K (PEPTIDES). As a Foreign Corporation, Ureka SARL is one of the more focused assignees in the PatentsView dataset. By volume, Ureka sits between Uppthera (6 patents, rank #43,802) and USHR Inc. (6 patents, rank #43,810) - the closest US assignees by grant volume. The composite Innovation Score of 31.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 3 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ureka SARL's 17.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ureka SARL against peers pursuing similar technology classes.
Who files at Ureka's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Uppthera
UPPTHERA
6 patents
- Urakami
URAKAMI LLC
6 patents
- Urban SKY
URBAN SKY
6 patents
- URC Ventures
URC Ventures, Inc.
6 patents
- US Spine
US SPINE, INC.
6 patents
- USA Intellectual…
USA Intellectual Property Holding, Inc.
6 patents
- Usenlight
USENLIGHT CORPORATION
6 patents
- USHR
USHR INC.
6 patents
- Ureka SARL ◀
UREKA SARL
6 patents
What this shows Ureka holds 6 patents at rank #43,806, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ureka
By rank, the assignees closest to #43,806 in granted patent volume.
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Ureka's primary technology class.
- The Regents Of The University Of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies Gmbh 678 in class
- Genentech, Inc. 565 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 513 in class
- The Trustees Of The University Of Pennsylvania 501 in class
- Novartis Ag 407 in class
- The Board Of Trustees Of The Leland Stanford Junior University 400 in class
Ureka's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 63% higher than 37% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 3 | 50.0% |
| 2021 | 1 | 16.7% |
| 2022 | 2 | 33.3% |
Which technologies does Ureka SARL patent most?
Top 9 of 9 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Ureka SARL hold?
Ureka SARL holds 6 US granted patents filed between 2019 and 2022, spanning 9 technology areas.
What is Ureka SARL's Innovation Score?
Ureka SARL has an Innovation Score of 31.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Ureka SARL focus on?
Ureka SARL's top technology area is C07K (PEPTIDES) with 5 patents. The company has filed patents in 9 CPC subclasses total.
Is Ureka SARL's patent filing rate increasing or decreasing?
Ureka SARL's recent filing velocity is +0% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Ureka SARL's patents?
Ureka SARL's patents average 17.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Ureka SARL patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Ureka's 6 grants land it in the top 63% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Ureka ranks #43,806 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C07K - see who else leads that technology area. C07K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.